Activin A down-regulates the phagocytosis of lipopolysaccharide-activated mouse peritoneal macrophages in vitro and in vivo

Cellular Immunology

Volumn 255, Issue 1-2, 2009, Pages 69-75

  Zhou, Jing ^a   Tai, Guixiang ^a   Liu, Haiyan ^a   Ge, Jingyan ^a   Feng, Ye ^a   Chen, Fangfang ^a   Yu, Fang ^a   Liu, Zhonghui ^a  

^a Basic Medical College   (China)

Author keywords

Activin; CD14; Lipopolysaccharide; Macrophage; MHC II; Phagocytosis

Indexed keywords

ACTIVIN A; CD14 ANTIGEN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITRIC OXIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL;

ACTIVINS; ANIMALS; ANTIGENS, CD14; CELLS, CULTURED; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HLA ANTIGENS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; PHAGOCYTOSIS; PINOCYTOSIS;

EID: 59349101542     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.11.001     Document Type: Article

References (33)

1. Gopinath V.K., Musa M., Samsudin A.R., and Sosroseno W. Role of interleukin-1beta and tumour necrosis factor-alpha on hydroxyapatite-induced phagocytosis by murine macrophages (RAW264.7 cells). Br. J. Biomed. Sci. 63 (2006) 176-178
2. Zhang X.J., Li Y., Tai G.X., Xu G.Y., Zhang P.Y., Yang Y., Lao F.X., and Liu Z.H. Effects of activin A on the activities of mouse peritoneal macrophages. Cell. Mol. Immunol. 2 (2005) 63-67
3. Crume K.P., Miller J.H., La Flamme A.C., and Peloruside A. An antimitotic agent, specifically decreases tumor necrosis factor-{alpha} production by lipopolysaccharide-stimulated murine macrophages. Exp. Biol. Med. 232 (2007) 607-613
4. Drozina G., Kohoutek J., Nishiya T., and Peterlin B.M. Sequential modifications in class II transactivator isoform 1 induced by lipopolysaccharide stimulate major histocompatibility complex class II transcription in macrophages. J. Biol. Chem. 281 (2006) 39963-39970
5. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
6. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., and Woo W. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321 (1986) 776-779
7. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., and Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321 (1986) 779-782
8. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8 (1994) 133-146
9. Brosh N., Sternberg D., Honigwachs-Sha'anani J., Lee B.C., Shav-Tal Y., Tzehoval E., Shulman L.M., Toledo J., Hacham Y., Carmi P., Jiang W., Sasse J., Horn F., Burstein Y., and Zipori D. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11: identification as a stroma-derived activin A. J. Biol. Chem. 270 (1995) 29594-29600
10. Yu J., Shao L.E., Frigon Jr. N.L., Lofgren J., and Schwall R. Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid. Immunology 88 (1996) 368-374
11. Abe M., Shintani Y., Eto Y., Harada K., Kosaka M., and Matsumoto T. Potent induction of activin A secretion from monocytes and bone marrow stromal fibroblasts by cognate interaction with activated T cells. J. Leukoc. Biol. 72 (2002) 347-352
12. Ebert S., Zeretzke M., Nau R., and Michel U. Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists. Neurosci. Lett. 413 (2007) 241-244
13. Werner S., and Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17 (2006) 157-171
14. Wang S.Y., Tai G.X., Zhang P.Y., Mu D.P., Zhang X.J., and Liu Z.H. Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Cytokine 42 (2008) 85-91
15. Yan Y., Wanshun L., Baogin H., Changhong W., Chenwei F., Bing L., and Liehuan C. The antioxidative and immunostimulating properties of d-glucosamine. Int. Immunopharmacol. 7 (2007) 29-35
16. Wei H., Xu Y., Cheng B., and Xiong Y. Synergistic effects of Lactobacillus rhamnosus ZDY114 and bovine colostrums on the immunological function of mouse in vivo and in vitro. Appl. Microbiol. Biotechnol. 75 (2007) 427-434
17. Miljkovica D., Cvetkovica I., Momcilovica M., Maksimovic-Ivanica D., Stosic-Grujicica S., and Trajkovicb V. Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells. Cell. Mol. Life Sci. 62 (2006) 2658-2668
18. Ziegler-Heitbrock H.W., and Ulevitch R.J. CD14: cell surface receptor and differentiation marker. Immunol. Today 14 (1993) 121-125
19. Ulevitch R.J., and Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13 (1995) 437-457
20. Kirkland T.N., Finley F., Leturcq D., Moriarty A., Lee J.D., Ulevitch R.J., and Tobias P.S. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 268 (1993) 24818-24823
21. Eto Y., Tsuji T., Takezawa M., Takano S., Yokogawa Y., and Shibai H. Purification and characterization of erythroid differentiation factor (EDF) isolated from human leukemia cell line THP-1. Biochem. Biophys. Res. Commun. 142 (1987) 1095-1103
22. Thomsen G., Woolf T., Whitman M., Sokol S., Vaughan J., and Vale W. Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63 (1990) 485-493
23. Liu Z.H., Shintani Y., Sakamoto Y., Harada K., Zhang C.Y., Fujinaka Y., Abe M., Goto T., and Saito S. Effects of LHRH, FSH and activin A on follistatin secretion from cultured rat anterior pituitary cells. Endocr. J. 43 (1996) 321-327
24. Sternberg D., Honigwachs-sha'anani J., Brosh N., Malik Z., Burstein Y., and Zipori D. Restrictin-P/stromal activin A, kills its target cells via an apoptotic mechanism. Growth Factors 12 (1995) 277-287
25. Ohguchi M., Yamato K., Ishihara Y., Koide M., Ueda N., Okahashi N., Noguchi T., Kizaki M., Ikeda Y., Sugino H., and Nisihara T. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 18 (1998) 491-498
26. Sugama S., Takenouchi T., Kitani H., Fujita M., and Hashimoto M. Activin as an anti-inflammatory cytokine produced by microglia. J. Neuroimmunol. 192 (2007) 31-39
27. Gayathri B., Manjula N., Vinaykumar Ks., Lakshmi B.S., and Balakrishnan A. Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF alpha, IL-1beta, NO and MAP kinases. Int. Immunopharmacol. 7 (2007) 473-482
28. Zhao W., An H., Zhou J., Xu H., Yu Y., and Cao X. Hyperthermia differentially regulates TLR4 and TLR2-mediated innate immune response. Immunol. Lett. 108 (2007) 137-142
29. Lee J.Y., Kim J.Y., Lee Y.G., Shin W.C., Chun T., Rhee M.H., and Cho J.Y. Hydroquinone, a reactive metabolite of benzene, reduces macrophage-mediated immune responses. Mol. Cells 23 (2007) 198-206
30. Ma Y., and Pope R.M. The role of macrophages in rheumatoid arthritis. Curr. Pharm. Des. 11 (2005) 569-580
31. Reynolds H.Y. Lung inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 171 (2005) 98-102
32. Martin G.E.M., Ask K., Gilpin S.E., Kolb M., and Gauldie J. The transforming growth factor-beta (TGF-β) family and pulmonary fibrosis. Respir. Dis. 3 (2006) 99-103
33. Sheppard D. Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 3 (2006) 413-417